BioSpace News Archive

Oncimmune Holdings plc (AIM: ONC.L), a leader in the development, manufacture and commercialisation of personalised immunodiagnostics for the screening, detection and care of cancer, today announces that its Spanish distributor, Sabartech, has signed an agreement to sell EarlyCDT—Lung as a screening test for the early detection of lung cancer through the hospitals and clinics of the Quirónsalud group (“Quirónsalud”)

Kaufman Hall, a leading provider of enterprise performance management (EPM) software, data, and management consulting services, announced today that Banner Health, one of the nation’s largest non-profit health systems, selected Axiom software solutions to optimize financial and operational performance.

Promotes charles knight as interim chief financial officer

The partnership is a major Ghadan 21 initiative to grow Abu Dhabi’s R&D ecosystem with a commitment of 300 million AED (81 million USD) to crowdsource innovation via a series of XPRIZE Abu Dhabi global competitions

Internationally respected physician-informatician will join institute April 1

On March 20, 2019, Alfa Chemistry announced that their catalyst subsite has been officially launched.

The new facility will become a state-of-the-art manufacturing and production site designed for late-stage and commercially-approved cell and gene therapy products.

These awards recognise Almac’s global reputation for excellence built over 50 years of client service across the drug development and commercialisation lifecycle and is the organisation’s seventh consecutive year of winning the awards.

Statement by U.S. Conference of Mayors President Steve Benjamin

India Globalization Capital, Inc. announces that, as of Wednesday, March 27, 2019, Hyalolex™, the Company’s cannabinoid-based, non-FDA approved product designed to assist in helping improve the lives of patients suffering from Alzheimer’s disease, will be available for purchase in select dispensaries in San Juan, Puerto Rico.